Clinical Trial Update: Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating metformin versus febuxostat for gout in obese, non-diabetic patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• metformin (metformin)

Snippet

Sponsor: Mostafa Bahaa | Conditions: Gout | Phase 2 | Status: RECRUITING